RE:RE:RE:COVID Fibrosis
I would be more than happy to own a stock that could treat all forms of fibrosis , i know that it is a multi -billions market.
I agree that if pre clinical data shows it worth going into PHASE I then they should do it cos after all a clinical PHASE I cost between $1.6 and $7M in United States.
But do not forget the chance of succeed according to the American council on science and health
in Autoimmune and inflammation (IPF belongs to that category? i think so but not 100% sure) disease is only 15.1%